Genetic engineering of hematopoiesis: current stage of clinical translation and future perspectives
Abstract Here I review the scientific background, current stage of development and future perspectives that I foresee in the field of genetic manipulation of hematopoietic stem cells with a special emphasis on clinical applications.
Saved in:
| Main Author: | Luigi Naldini |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2019-01-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.201809958 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lentiviral vectors escape innate sensing but trigger p53 in human hematopoietic stem and progenitor cells
by: Francesco Piras, et al.
Published: (2017-06-01) -
Sickle cell disease: understanding pathophysiology, clinical features and advances in gene therapy approaches
by: Muhammad Taher, et al.
Published: (2025-08-01) -
Research progress and considerations for thalassemia gene therapy
by: GAO Xinjie, et al.
Published: (2025-05-01) -
Pervasive supply of therapeutic lysosomal enzymes in the CNS of normal and Krabbe‐affected non‐human primates by intracerebral lentiviral gene therapy
by: Vasco Meneghini, et al.
Published: (2016-03-01) -
Genome editing for scalable production of alloantigen‐free lentiviral vectors for in vivo gene therapy
by: Michela Milani, et al.
Published: (2017-08-01)